INHALE logo

INHALE Publications

Enne VI, Aydin A, Baldan R, et al​. Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study. Thorax Published Online First: 13 January 2022.

Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance. Enne VI, Personne Y, Grgic L, Gant V, Zumla A.Curr Opin Pulm Med. 2014 May;20(3):252-8. PMID: 24614243.

Understanding decisions about antibiotic prescribing in ICU: an application of the Necessity Concerns Framework. Pandolfo AM, Horne R, Jani Y, et al. BMJ Quality & Safety Published Online First: 07 June 2021.

WP4:Intensivists’ beliefs about rapid multiplex molecular diagnostic testing and its potential role in improving prescribing decisions and antimicrobial stewardship: a qualitative study. Pandolfo AM, Horne R, Jani Y, et al. Antimicrob Resist Infect Control 10, 95 (2021).

Review of health economic models exploring and evaluating treatment and management of hospital-acquired pneumonia and ventilator-associated pneumonia. Wagner AP, Enne VI, Livermore DM, Craig JV, Turner DA; INHALE Study Group. J Hosp Infect. 2020 Dec;106(4):745-756

COVID sub-study pre-print

Organisms causing secondary pneumonias in COVID-19 patients at 5 UK ICUs as detected with the FilmArray test. Dhesi, Z, Enne, V.I, Brealey, D. et al.

​ ​

WP3 protocol paper

High, J., Enne, V.I., Barber, J.A. et al. INHALE: the impact of using FilmArray Pneumonia Panel molecular diagnostics for hospital-acquired and ventilator-associated pneumonia on antimicrobial stewardship and patient outcomes in UK Critical Care—study protocol for a multicentre randomised controlled trial. Trials 22, 680 (2021).